Background Comorbidity is highly prevalent between substance use disorders (SUDs) and
schizophrenia. This systematic review and meta-analysis estimated prevalence rates of …

With the increasing push to legalize cannabis in Western nations, there is a need to gage
the potential impact of this policy change on vulnerable populations, such as those with …

The American Psychiatric Association Practice Guideline for the Treatment of Patients With
Schizophrenia seeks to reduce these substantial psychosocial and public health …

Background We assessed the prevalence and correlates of lifetime substance use disorders
in people with first episode psychosis using the baseline data from the Recovery After an …

This study aimed to systematically review and synthesise the available evidence on the
prevalence and associations between psychotic-like experiences (PLEs) and substance use …

With the proposed Canadian July 2018 legalization of marijuana through the Cannabis Act,
a thorough critical analysis of the current trials on the efficacy of medicinal marijuana (MM) …

Increasing evidence indicates a relationship between cannabis use and psychosis risk.
Specific factors, such as determinants of cannabis use or the genetic profile of cannabis …

Objective We aimed to assess whether individuals at ultra high risk (UHR) for psychosis
have higher rates of cannabis use and cannabis use disorders (CUD s) than non‐UHR …

BackgroundCannabis use has been linked to psychotic disorders but this association has
been primarily observed in the Global North. This study investigates patterns of cannabis …

Background and Objectives: Anorexia nervosa (AN) is a complex disorder whose
etiopathogenesis involves both biological and environmental factors. The aims of the …